Assessment of nitric oxide and uric acid in patients of leprosy


  • Sangeeta B. Trimbake Department of Biochemistry, MIMER Medical College, Talegaon Dhabade, Pune, Maharashtra, India
  • Alka N. Sontakke Department of Biochemistry, MIMER Medical College, Talegaon Dhabade, Pune, Maharashtra, India
  • Rohini P. Gaikwad Department of Dermatology, MIMER Medical College, Talegaon Dhabade, Pune, Maharashtra, India



Leprosy, Nitric oxide, Oxidative stress, Uric acid


Background: Leprosy is an old, dreaded infectious disease caused by the obligate intracellular bacterium mycobacterium leprae. Leprosy still continues to be a significant public health problem in few countries including India. Oxidative stress caused by derangement in the balance between ROS and natural antioxidants plays a crucial role in the pathogenesis of leprosy. Hence this study attempts to assess the oxidative stress and antioxidant status in terms of Nitric oxide and uric acid.

Methods: A case control observational study was carried out in100 untreated leprosy patients and compared with 50 healthy controls.  Leprosy patients were divided as paucibacillary and multibacillary. Serum Nitric oxide and uric acid levels were estimated in both groups to find out correlation of Nitric Oxide with uric acid.

Results: There was a significant rise in serum NO in both PB and MB leprosy as compared to controls. The uric acid level was significantly decreased in both PB and MB leprosy patients as compared to controls.

Conclusions: Elevated NO levels indicate oxidative stress in leprosy patients, denoting its crucial involvement in the pathogenesis and nerve damage in leprosy. Low uric acid indicates decrease defence of antioxidants in leprosy.


Narasimha R, Sujal S. Current situation of leprosy in India and its future implications. Ind Dermatol Online J. 2018;9:83-9.

Vijayaraghavan R, Suribabu C, Sekar B, Oommen P. Protective role of vitamin E. on oxidative stress in Hansen’s disease patients. Europ J Clin Nutr. 2005;59:1121-8.

Lima E, Roland I, Maroja M, Marcon J. Vitamin A and lipidperoxidation in patients with different forms of leprosy. Rev Inst Med Trops Paulo. 2007;49:211-4.

Qadoumi M, Becker I, Donhuser N, Rollinghoff M, Bogdan C. Expression of iNOS in skin lesions of patients with American cutaneous Leishmaniasis. Infect Immu. 2002;70:4638-42.

Schon T, Hernandez R, Negesse Y, Leekassa R, Sund T, Brittion S. Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions. British J Dermatol. 2001;145:809-17.

Niki E. Lipid peroxidation: physiological levels and duel biological effects. Free Radic Biol Med. 2009;47:469-84.

Waring WS. Uric acid: an important antioxidant in acute ischaemic stroke. QJM. 2002 Oct 1;95(10):691-3.

Aggarval H, Sharma P, Jaswal T. Evaluation of renal profile in patients of leprosy. J Indian Acad Clin Med. 2004;5:316-21

Olivera R, Silva J, Souza C. Evaluation of renal function in leprosy: a study of 59 consecutive patients. Nephrol Dial Transplant. 2008;23:256-62.

Osadolor H, Okosun R. Non enzymatic antioxidants status of leprosy patients in a leprosarium settlement in Nigeria. Biochem. 2014;26:52-4.

Sunita G, Thorat A, Mhaske C. Role of uric acid as an endogenous antioxidant in leprosy. Antiseptic. 2009;106:78-9.

WHO committee. World Health Oragnisation. Guide to eliminate leprosy as a public health problem, 2000. Available at: https;// 6 May 2000.

Cortas N, Wakid N. Determination of inorganic nitrite in serum and urine by a kinetic cadmium reduction method. Clin Chem. 1990;36:1440-3.

Searcy RL. Diagnostic Biochemistry. Clinical diagnosis and management to clinical methods. McGraw- Hill New York; 1969:556-564.

Garad A, Suryakar A, Shinde C. Study of nitric oxide synthesis and its oxidative effects on serum proteins in leprosy. Inter J Pharma Biol Chem Sci. 2014;3:18-24.

Hackam D, Rotstein O, Zhang W, Gruenheid S, Gross P, Grinstein S. Host resistance to intracellular infection: Mutation of natural resistance associated macrophage protein I impairs phagosomal acidification. J Exp Med. 1998;188:351-64.

Cooper A, Adams L, Dalton D. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 2002;10:221-6.

Boga P, Shetty P, Khan Y. Nitric oxide metabolites in sera of patients across the spectrum of leprosy. Ind J Lepr. 2010;82:123-9.

Tyasa R, Jose L, Claudio G, Rosivaldo D, Matra C. Antioxidant factors, nitric oxide levels, and cellular damage in leprosy patients. Rev Soc Bras Med Trop. 2013;46:1-7.

Fatima M, Nancy W, Jehan H. Serum nitric oxide metabolites in leprosy patients as a parameter of prognostic value. J Egypt Women’s Dermatol Soc. 2015;12:44-8.

Khanolkar Y, Snowdon D, Lockwood D. Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta)in leprosy lesions. Clin Exp Immunol. 1998;113:438-42.

Squadrito G, Cueto R, Splenser A, Valavanidis A, Zhang H, Uppu R, et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys. 2000;376:333-7.

Trimbake S, Sontakke A, Dhat V. Oxidative stress and antioxidant vitamins in leprosy. Int j Res Med Sci. 2013;3:101-4.




How to Cite

Trimbake, S. B., Sontakke, A. N., & Gaikwad, R. P. (2020). Assessment of nitric oxide and uric acid in patients of leprosy. International Journal of Research in Medical Sciences, 8(3), 855–858.



Original Research Articles